C07D 235/16
Radicals substituted by carbon atoms having three bonds to hetero atoms with
Official title: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D235/16 (Radicals substituted by carbon atoms having three bonds to hetero atoms with) appears on 303 US grants and 259 published applications in this corpus.
Search patents in C07D- Granted patents
- 303
- Published applications
- 259
- Assignees
- 196
- Inventors
- 1,033
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 6 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 12 | 0 |
| 1997 | 17 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 10 | 0 |
| 2001 | 11 | 1 |
| 2002 | 16 | 7 |
| 2003 | 8 | 11 |
| 2004 | 3 | 10 |
| 2005 | 4 | 6 |
| 2006 | 5 | 11 |
| 2007 | 5 | 5 |
| 2008 | 5 | 10 |
| 2009 | 8 | 18 |
| 2010 | 3 | 11 |
| 2011 | 8 | 11 |
| 2012 | 11 | 10 |
| 2013 | 10 | 15 |
| 2014 | 14 | 25 |
| 2015 | 18 | 13 |
| 2016 | 14 | 12 |
| 2017 | 15 | 11 |
| 2018 | 6 | 6 |
| 2019 | 6 | 7 |
| 2020 | 2 | 12 |
| 2021 | 6 | 9 |
| 2022 | 11 | 9 |
| 2023 | 3 | 11 |
| 2024 | 6 | 9 |
| 2025 | 9 | 7 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Histone deacetylase inhibitors26 May 2026US 12,637,433 B2The University of Queensland
- PGDH inhibitors and methods of making and using24 Feb 2026US 12,559,493 B2Myoforte Therapeutics, Inc.
- Substituted benzimidazole derivative and use thereof13 Jan 2026US 12,522,569 B2Chengdu FANXI Biopharma Co., Ltd.
- GLP-1R modulating compounds16 Dec 2025US 12,497,382 B2Gilead Sciences, Inc.
- (r)-n-(4-(chlorodifluoromethoxy)phenyl)-2-(difluoromethyl)-1-(1-hydroxypropan-2-yl)-7-(pyrimidin-5-yl)-1H-benzo[d]imidazole-5-carboxamide, or a pharmaceutically acceptable salt or tautomer thereof, for treating certain leukemias28 Oct 2025US 12,454,524 B2Terns Pharmaceuticals, Inc.
- Pgdh inhibitors and methods of making and using13 Aug 2026US 2026/0234142 A1Myoforte Therapeutics, Inc.
- Inhibitors of protein arginine deiminase 1 and methods of preparation and use thereof8 Jan 2026US 2026/0008755 A1
- Selective hdac6 inhibitor4 Dec 2025US 2025/0368608 A1Dana-Farber Cancer Institute, Inc.
- Method for preparing 4-[5-[bis(2-chloroethyl)amino]-1-methyl-1h-benzo[d]imidazol-2-yl]butyric acid alkyl esters and formylated derivatives25 Sep 2025US 2025/0295636 A1Heraeus Precious Metals GmbH & Co. KG
- Cyclic compounds for organic electroluminescent devices18 Sep 2025US 2025/0295028 A1Merck Patent GmbH
Most cited
By later US patents
- Angiotensin II receptor blocking benzimidazoles184US 4,880,804 AE. I. Du Pont de Nemours and Company · 1989
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions73US 6,414,008 B1Boehringer Ingelheim Pharma GMBH & CO.KG · 2002
- Benzimidazole derivatives as therapeutic agents73US 7,329,684 B2TransTech Pharma, Inc. · 2008